AIM
GEN

Acrospire Investment Management’s Genesis Healthcare, Inc. GEN Stock Holding History

Acrospire Investment Management’s Portfolio GEN Stock Details GEN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		– Sell
-9,102
Closed -$16K – 1754
2017
Q2 		$16K Buy
9,102
+7,341
+417% +$15.6K 0.02% 1654
2017
Q1 		$5K Sell
1,761
-13,673
-89% -$49.1K ﹤0.01% 2023
2016
Q4 		$66K Buy
15,434
+14,992
+3,392% +$49.4K 0.03% 1222
2016
Q3 		$1K Sell
442
-9,399
-96% -$21.6K ﹤0.01% 1942
2016
Q2 		$17K Buy
+9,841
New +$20.1K 0.01% 1591

Other funds holding GEN

CPA
Columbia Pacific Advisors Seattle, Washington $31M AUM 29.53% 1-Year Est. Return
HighTower Advisors
HighTower Advisors Chicago, Illinois $103B AUM 28.65% 1-Year Est. Return
FWC
First Washington Corp Seattle, Washington $353M AUM 41.46% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
V3 Capital Management Dallas, Texas $33.4M AUM 5.9% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
FM
Forward Management San Francisco, California $907M AUM 0.46% 1-Year Est. Return

Acrospire Investment Management's GEN Position: Q3 2017 in Review

Acrospire Investment Management sold out of Genesis Healthcare, Inc. (GEN) in Q3 2017, closing a stake of 9,102 shares — an estimated $16K sold.

Acrospire Investment Management first reported a position in GEN in Q2 2016 and held it in 5 quarters. The position peaked at $66K in Q4 2016. 73 funds tracked by Wall St. Rank hold GEN as of Q3 2017.

  • Acrospire Investment Management reported no remaining Genesis Healthcare, Inc. position as of Q3 2017 after selling out during the quarter.
  • Acrospire Investment Management sold 9,102 Genesis Healthcare, Inc. shares in Q3 2017, an estimated $16K.
  • Acrospire Investment Management first reported a position in Genesis Healthcare, Inc. in Q2 2016 and held it in 5 quarters.
  • Acrospire Investment Management's Genesis Healthcare, Inc. position peaked at $66K in Q4 2016.
  • 73 funds tracked by Wall St. Rank held Genesis Healthcare, Inc. as of Q3 2017.

Based on Acrospire Investment Management's 13F filing for Q3 2017, filed 26 Oct 2017.